Clinical trial prediction markets raise research integrity fears, report says
Regulation · SectorWire deskSource published
Summary
Prediction markets that let traders wager on clinical trial results and FDA drug approvals risk compromising research, healthcare professionals warned, according to a New York Times report. Critics cited possible changes in trial participant and researcher behaviour and scope for insider trading. A Change.org petition by biotechnology professional David Tsai urges regulators to prohibit markets linked to clinical trials.
Why it matters
Prediction-market operators face scrutiny over contracts on medical outcomes, a model that could invite regulatory action beyond gambling.
Cite as: SectorWire, “Clinical trial prediction markets raise research integrity fears, report says”, 29 July 2026, https://sectorwire.news/item/clinical-trial-prediction-markets-raise-research-integrity-fears-repor/